You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Ascites

Showing 1 - 25 of 3,558
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

QOL and Sarcopenia in Patients With Ascites

Not yet recruiting
  • Ascites Hepatic
  • Ascites, Malignant
  • Quality of Life surveys
  • Philadelphia, Pennsylvania
    University of Pennsylvania Perelman School of Medicine
Feb 10, 2023

Malignant Ascites Trial in Taichung (Nivolumab, Pembrolizumab)

Enrolling by invitation
  • Malignant Ascites
  • Taichung, Please Select, Taiwan
    China Medical University Hospital
Feb 16, 2023

Cirrhosis, Liver Failure Trial (Empagliflozin 10 MG, Matching Placebo)

Not yet recruiting
  • Cirrhosis
  • Liver Failure
  • Empagliflozin 10 MG
  • Matching Placebo
  • (no location specified)
Feb 2, 2023

Ascites Hepatic Trial in Alexandria (Empagliflozin 10 MG, Diuretics)

Recruiting
  • Ascites Hepatic
  • Alexandria, Egypt
    Alexandria University
Jun 18, 2022

Point-of-Care Echocardiography to Assess Impact of Dynamic

Recruiting
  • Cirrhosis, Liver
  • +4 more
  • Echocardiographic assessment
  • Chandigarh, Delhi, India
    PGIMER
Jan 17, 2023

Immune Checkpoints in Intraabdominal Ascites Fluid

Completed
  • Colorectal Cancer
  • Flow-cytometric analysis
  • Istanbul, Turkey
    Ufuk Oguz Idiz
Dec 4, 2022

Malignant Ascites Trial (Serplulimab, Molgramostim, Hypofractionated radiotherapy/Sterotactic body radiotherapy)

Not yet recruiting
  • Malignant Ascites
  • (no location specified)
Aug 11, 2022

Liver Cirrhosis, Cirrhosis, Ascites Trial in Redwood City (Empagliflozin 10 MG)

Recruiting
  • Liver Cirrhosis
  • +4 more
  • Empagliflozin 10 MG
  • Redwood City, California
    Stanford University Digestive Health Clinic
Mar 21, 2022

Ascites Trial in Houston (Albumin)

Recruiting
  • Ascites
  • Houston, Texas
    Baylor St' Lukes Medical center
May 10, 2023

Hypertension, Portal, Ascites Trial in Los Angeles (Gore® Viatorr® Endoprosthesis with controlled expansion, Large Volume

Recruiting
  • Hypertension, Portal
  • Ascites
  • Gore® Viatorr® Endoprosthesis with controlled expansion
  • Large Volume Paracentesis with albumin infusion
  • Los Angeles, California
    UCLA Medical Center
Sep 1, 2022

Refractory Malignant Ascites Trial in Shanghai (Oncorine (H101))

Recruiting
  • Refractory Malignant Ascites
  • Oncorine (H101)
  • Shanghai, China
    Fudan University Shanghai Cancer Center
Mar 15, 2022

Cancer & Immune Cells in Ascites Fluid of Ovarian Cancer

Recruiting
  • Ovarian Cancer
    • Albuquerque, New Mexico
      University of New Mexico Cancer Center
    Oct 4, 2022

    Ascites Hepatic Trial in Bucheon (KARAHOC device, Angiocatheter)

    Enrolling by invitation
    • Ascites Hepatic
    • KARAHOC device
    • Angiocatheter
    • Bucheon, Gyeonggi Do, Korea, Republic of
      Soon Chun Hyang University Bucheon Hospital
    Oct 10, 2022

    Refractory Malignant Ascites Trial in Shanghai (H101, Tislelizumab)

    Recruiting
    • Refractory Malignant Ascites
    • Shanghai, China
      Fudan University Shanghai Cancer Center
    Apr 2, 2022

    Application of NGS in Ascites Infection

    Recruiting
    • Ascites Infection
    • Liver Diseases
    • Next generation sequence
    • Chongqing, Chongqing, China
      The Second Affiliated Hospital of Chongqing Medical University
    Aug 8, 2022

    Ascites, Paracentesis, Cirrhosis Trial in France (Alphapump, Ascites puncture)

    Recruiting
    • Ascites
    • +2 more
    • Alphapump
    • Ascites puncture
    • Amiens, France
    • +8 more
    Jun 9, 2022

    Management of Malignant Ascites by Interventional Radiology

    Withdrawn
    • Refractory Malignant Ascites
    • Paracentesis
    • +2 more
    • Philadelphia, Pennsylvania
      Abramson Cancer Center of the University of Pennsylvania
    Jan 11, 2022

    Hepatic Ascites Trial in Guangdong (Recombinant Human Serum Albumin, Human serum albumin)

    Recruiting
    • Hepatic Ascites
    • Recombinant Human Serum Albumin
    • Human serum albumin
    • Guangdong, Shenzheng, China
      Shenzheng Protgen Ltd
    Feb 9, 2022

    Refractory Ascites in Children With Cirrhosis Trial in New Delhi (Midodrine, Standard medical treatment)

    Recruiting
    • Refractory Ascites in Children With Cirrhosis
    • New Delhi, India
      ILBS
    Nov 11, 2021

    Ascites, Fluid Loss Trial in Dallas (Dermabond)

    Enrolling by invitation
    • Ascites
    • Fluid Loss
    • Dermabond
    • Dallas, Texas
      Methodist Dallas Medical Center Pharmacy
    Oct 21, 2022

    Gastric Cancer, Pancreatic Cancer Trial in Fukuoka-shi (Phase I part, Phase II part)

    Recruiting
    • Gastric Cancer
    • Pancreatic Cancer
    • Phase I part
    • Phase II part
    • Fukuoka-shi, Fukuoka, Fukuoka, Japan
      Kyushu University Hospital
    Jun 24, 2022

    Pleural Effusion, Ascites Trial (EFFIDRAIN, Manual drainage system)

    Not yet recruiting
    • Pleural Effusion
    • Ascites
    • EFFIDRAIN
    • Manual drainage system
    • (no location specified)
    Feb 9, 2023

    Malignant Fluid Cells as a Biomarker for Rapid Therapy Guidance

    Recruiting
    • Pleural Effusion, Malignant
    • +2 more
      • Oakland, California
        xCures
      Aug 15, 2022

      Cirrhotic Ascites Trial in Changchun (OrsHSA, HSA)

      Recruiting
      • Cirrhotic Ascites
      • Changchun, Jilin, China
        First Hospital of Jilin University
      Nov 11, 2021

      Hepatic Ascites Trial in Guangdong (Recombinant Human Serum Albumin, Human serum albumin)

      Not yet recruiting
      • Hepatic Ascites
      • Recombinant Human Serum Albumin
      • Human serum albumin
      • Guangdong, Shenzhen, China
        Shenzhen Protgen Ltd
      May 5, 2023